Cheap-to-serve incremental business: management says the next tranche of volume costs it almost nothing extra
The model's full reasoning — Q1 2016 call → NOWe need to determine if management conveys that the cost of serving the next increment of business is unusually low because the company has already built and paid for the necessary resources, and that additional business of that kind is already arriving now. Let's analyze the transcript. The company is Curis, a biotech. They have programs: CUDC-907 (a drug in clinical trials), CA170 (a small molecule checkpoint antagonist), and Erivedge (commercialized by partners). They also have an IRAK4 inhibitor in preclinical. The question is about incremental business being cheap to serve because the base is already built and paid for, and that additional business is arriving. Look for any language about capacity, infrastructure, or fixed costs that are already in place and can handle more without proportional spending. Also look for evidence of increasing volume. In the transcript, management discusses clinical trials, enrollment, etc. They mention that CUDC-907 Phase 2 is ongoing, and they have completed enrollment in the monotherapy arm of Phase 1. They also mention CA170 is expected to enter the clinic this quarter. They talk about Erivedge being commercialized by partners. But is there any mention of "cost of serving the next increment" being low? For a biotech, the "business" might be drug development, but the question is about incremental business like additional patients, additional sales, etc. However, the company is not yet generating significant revenue from its own products; they have royalty revenue from Erivedge. Management does not discuss any capacity or infrastructure that is underutilized. They talk about clinical trials, but that's not about serving more business cheaply. They don't mention that they have already built a salesforce or manufacturing capacity that can handle more volume. They do mention that they have increased headcount in clinical development, but that's not about incremental business being cheap. The only revenue is from Erivedge royalties, which are from partners. They don't discuss any incremental business arriving. There is no mention of "already built and paid for" base that can carry more volume. The company is investing in R&D, which is spending. Thus, the answer is NO. We need to be careful: the question asks if management conveys that the cost of serving the next increment of business has become unusually low.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| TGLS | Tecnoglass Inc. | Q2 2023 | 2023-08-08 | A |
| ADPT | Adaptive Biotechnologies Corporation | Q4 2022 | 2023-02-14 | C+ |
| SIBN | SI-BONE, Inc. | Q3 2022 | 2022-11-07 | C+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| HFWA | Heritage Financial Corporation | Q4 2021 | 2022-01-27 | A |
| AMC | AMC Entertainment Holdings, Inc. | Q2 2021 | 2021-08-09 | D |
| ESRT | Empire State Realty Trust, Inc. | Q2 2021 | 2021-07-29 | C+ |
| UMH | UMH Properties, Inc. | Q3 2018 | 2018-11-02 | C+ |
| WES | Western Midstream Partners, LP | Q3 2018 | 2018-10-31 | D |
| SATS | EchoStar Corporation | Q1 2018 | 2018-05-10 | C+ |
| ATI | Allegheny Technologies Incorporated | Q1 2018 | 2018-04-24 | B |
SATS · Q1 2018 → YESThe question is about whether management conveys that the cost of serving the next increment of business has become unusually low, meaning additional volume can be delivered with already built and pai...NO The transcript shows management describing high growth with significant upfront acquisition costs, fixed costs leading to margin expansion as growth slows, and beams filling up faster than expected on Jupiter-2 (implying approaching capacity limits rather than excess capacity). However, there is no clear indication of an already-built, underutilized base where additional business is arriving on resources already paid for without new capacity investment. Instead, they highlight ongoing build-out (Jupiter-3 in 2021) and potential slowdowns, which aligns with the "NO" criteria for being near limits or in a growth cycle requiring new spending.
ATI · Q1 2018 → YESThe question is about whether management conveys that the cost of serving the next increment of business has become unusually low, meaning additional volume can be delivered with already built and pai...YES Management describes the HPMC segment’s leverage from “additional volume across our asset base” and “utilization increases across our isothermal and conventional forging assets” that already generated “significant incremental margin growth,” with next-generation jet engine sales up 65% and now at 48% of total jet engine sales. They state they are “well positioned both in capability and capacity to continue to benefit from these trends well into the future” after noting the fourth press is coming on stream in a couple of years.
UMH · Q3 2018 → YESThe question is about whether management conveys that the cost of serving the next increment of business has become unusually low, meaning additional volume can be delivered with already built and pai...YES The transcript shows management conveying exactly this situation: the company already owns 3,600 vacant sites (most acquired) plus 6,215 rental homes (93.3% occupied), so the next increment of rental-home business can be served on infrastructure already paid for and in place. They explicitly call the rental program “the most efficient way to fill the vacant sites,” and they are already adding 608 homes this year on track for 800, with Same-Property occupancy rising to 83.2% and expense ratios improving as occupancy climbs.